A086220 Stock Overview
Manufactures and sells functional health and general food, and cosmetic products. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Kwangdong Healthbio Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩1,659.00 |
| 52 Week High | ₩3,800.00 |
| 52 Week Low | ₩1,315.00 |
| Beta | 0 |
| 1 Month Change | -1.37% |
| 3 Month Change | -13.86% |
| 1 Year Change | -38.56% |
| 3 Year Change | -33.51% |
| 5 Year Change | -11.28% |
| Change since IPO | -40.75% |
Recent News & Updates
Recent updates
Shareholder Returns
| A086220 | KR Personal Products | KR Market | |
|---|---|---|---|
| 7D | 14.8% | -0.7% | -1.9% |
| 1Y | -38.6% | -10.7% | -9.5% |
Return vs Industry: A086220 underperformed the KR Personal Products industry which returned -10.7% over the past year.
Return vs Market: A086220 underperformed the KR Market which returned -9.5% over the past year.
Price Volatility
| A086220 volatility | |
|---|---|
| A086220 Average Weekly Movement | 10.9% |
| Personal Products Industry Average Movement | 7.5% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.8% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A086220's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A086220's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | n/a | n/a | www.kdhealthbio.com |
Kwangdong Healthbio Co., Ltd. manufactures and sells functional health and general food, and cosmetic products. The company offers functional health food products for applications in the areas of intestines, immunity, blood circulation, cognitive ability improvement, cavity, blood sugar control, anti-oxidation, memory improvement, prostate health, fatigue improvement, joint/bone health, skin care, liver health, calcium absorption, cholesterol, blood pressure control, eye care, ergogenic ability improvement, body fat, neutral fat in blood, relaxation, and urinary-track. It also provides general food products, such as liquid products, including liquid tea, fruit/vegetable beverages, and other processed goods; powder products comprising weight control food products, special medical purpose food products, and other processed goods; and candy and jelly products.
Kwangdong Healthbio Co., Ltd. Fundamentals Summary
| A086220 fundamental statistics | |
|---|---|
| Market cap | ₩16.92b |
| Earnings (TTM) | ₩0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A086220 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A086220 income statement (TTM) | |
|---|---|
| Revenue | ₩0 |
| Cost of Revenue | ₩0 |
| Gross Profit | ₩0 |
| Other Expenses | ₩0 |
| Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A086220 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 15:09 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | N/A |
| Annual Earnings | N/A |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Kwangdong Healthbio Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|